Khorana risk score and PROTECHT risk score as prediction models of venous thromboembolism in cancer outpatients receiving chemotherapy: a retrospective analysis

被引：0
|
作者：
Barni, S. [1 ]
Labianca, R. [2 ]
Verso, M. [3 ]
Gasparini, G. [4 ]
Bonizzoni, E. [5 ]
Mandala, M. [2 ]
Brighenti, M. [6 ]
Petrelli, F. [1 ]
Bianchini, C. [7 ]
Perrone, T. [7 ]
Agnelli, G. [3 ]
机构：
[1] Treviglio Hosp, Med Oncol Dept, Treviglio, Italy
[2] Osped Riuniti Bergamo, Med Oncol Unit, Oncol & Hematol Dept, I-24100 Bergamo, Italy
[3] Univ Perugia, Internal & Vasc Med Stroke Unit, I-06100 Perugia, Italy
[4] San Filippo Neri Hosp, Dept Oncol, Rome, Italy
[5] Univ Milan, Inst Med Stat & Biometry, I-20122 Milan, Italy
[6] Cremona Hosp, Med Oncol Dept, Cremona, Italy
[7] Italfarmaco SpA, Dept Sci, Cinisello Balsamo, Italy
来源：
THROMBOSIS RESEARCH | 2012年 / 129卷
关键词：
D O I：
10.1016/S0049-3848(12)70061-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [1] A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
    Melina Verso
    Giancarlo Agnelli
    Sandro Barni
    Giampietro Gasparini
    Roberto LaBianca
    Internal and Emergency Medicine, 2012, 7 : 291 - 292
  • [2] A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
    Verso, Melina
    Agnelli, Giancarlo
    Barni, Sandro
    Gasparini, Giampietro
    LaBianca, Roberto
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (03) : 291 - 292
  • [3] A modified Khorana risk score model for venous thromboembolism in ambulatory cancer patients receiving chemotherapy: the Protecht score
    Verso, M.
    Agnelli, G.
    LaBianca, R.
    Gasparini, G.
    Barni, S.
    Bonizzoni, E.
    Brighenti, M.
    Mandala', M.
    Petrelli, F.
    Bianchini, C.
    Perrone, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 639 - 639
  • [4] Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
    Havlucu, Yavuz
    Kizilirmak, Deniz
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [5] The performance of Khorana risk score for prediction of venous thromboembolism in patients with lung cancer: A retrospective cohort study
    Kizilirmak, Deniz
    Fidan, Ugur
    Havlucu, Yavuz
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2024, 72 (02): : 114 - 119
  • [6] Validation and comparison of the Protecht, Conko, and Khorana score for prediction of venous thromboembolism in ambulatory cancer patients: a retrospective cohort study
    Guman, N. A.
    Mulder, F. I.
    van Es, N.
    Beerepoot, L. V.
    van Laarhoven, H.
    Lolkema, M.
    Buller, H. R.
    THROMBOSIS RESEARCH, 2021, 200 : S65 - S66
  • [7] PERFORMANCE OF KHORANA RISK SCORE FOR PREDICTION OF VENOUS THROMBOEMBOLISM IN PATIENTS OF HEPATOCELLULAR CARCINOMA
    Wang, Yuchen
    Attar, Bashar M.
    Fuentes, Harry
    Yu, Jie
    Simons-Linares, C. Roberto
    Tafur, Alfonso J.
    GASTROENTEROLOGY, 2017, 152 (05) : S1179 - S1179
  • [8] Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma
    Wang, Y.
    Attar, B. M.
    Fuentes, H. E.
    Yu, J.
    Zhang, Huiyuan
    Tafur, A. J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (03) : 471 - 476
  • [9] The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer
    van Es, N.
    Franke, V. F.
    Middeldorp, S.
    Wilmink, J. W.
    Buller, H. R.
    THROMBOSIS RESEARCH, 2017, 150 : 30 - 32
  • [10] FREQUENCY OF VENOUS THROMBOEMBOLISM AND ITS ASSOCIATION TO KHORANA RISK SCORE IN PATIENTS RECEIVING CHEMOTHERAPY AT GOULBURN VALLEY HEALTH
    Dhar, Patrick
    Torres, Javier
    Tamjid, Babak
    Saqib, Ayesha
    Wong, Zee Wan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 121 - 121
12345